Skip to main content

A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC)

OCS Liver DCD Trial

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about OCS Liver DCD Trial

Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms

Postop Pain Control in Hip Fracture Surgeyr: Fascia Iliaca Compartment Block Versus Fracture Block

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Postop Pain Control in Hip Fracture Surgeyr: Fascia Iliaca Compartment Block Versus Fracture Block

Targeting Non-virally Suppressed Adults With Alcohol Use Disorder in HIV Primary Care

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Targeting Non-virally Suppressed Adults With Alcohol Use Disorder in HIV Primary Care

Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix Cancer

A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

OCS Liver PROTECT Continued Access Protocol

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about OCS Liver PROTECT Continued Access Protocol

STRIVE Post-Market Registry Study

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about STRIVE Post-Market Registry Study

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 74
  • Page 75
  • Page 76
  • Page 77
  • Page 78
  • Page 79
  • Page 80
  • Page 81
  • Page 82
  • …
  • Next page Next
  • Last page Last
Subscribe to